A. Vassout

2.8k citations

31 papers · 2.3k indexed · 1 hit paper · h-index 17

Impact in

Biological Psychiatry top 1%
- Tryptophan and brain disorders
Behavioral Neuroscience top 1%
- Stress Responses and Cortisol

Papers in

Cellular and Molecular Neuroscience 22
- Neuroscience and Neuropharmacology Research 12
- Neurotransmitter Receptor Influence on Behavior 10
- Neuropeptides and Animal Physiology 5
Behavioral Neuroscience 4
- Stress Responses and Cortisol 4

Co-authors: Cédric Mombereau John F. Cryan C. Gentsch A. Delini‐Stula Will Spooren Ralf Kühn F. Gasparini Stanley J. Roux
Journals: European Journal of Pharmacology (3 papers)Pharmacopsychiatry (3 papers)Behavioural Brain Research (2 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
Partner nations: Switzerland Poland United Kingdom

In The Last Decade

A. Vassout

31 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice 2005 · 1.3k citations

Peers

Countries citing papers authored by A. Vassout

Since Specialization

Citations

This map shows the geographic impact of A. Vassout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Vassout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Vassout more than expected).

Fields of papers citing papers by A. Vassout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Vassout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Vassout. The network helps show where A. Vassout may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Vassout, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Vassout Line = papers co-authored together A. Vassout links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain Neuropharmacology ·Dominik Feuerbach, Kurt Lingenhoehl, Hans-Rudolf Olpe, A. Vassout, C. Gentsch, Frédérique Chaperon, Joachim Nozulak, Albert Enz, Graeme Bilbe, Kevin H. McAllister, Daniël Hoyer	2008	103
2	SAR of the arylpiperazine moiety of obeline somatostatin sst1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Konstanze Hurth, Albert Enz, Philipp Floersheim, C. Gentsch, Daniël Hoyer, Daniel Langenegger, Peter Neumann, Hidetada Moroi, Donna Broadhurst, J.J. Meleh, A. Vassout, Thomas Troxler	2007	8
3	The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice Neuroscience & Biobehavioral Reviews ·John F. Cryan, Cédric Mombereau, A. Vassout Hit paper breakdown →	2005	1294
4	In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: Review article Amino Acids ·Ralf Kühn, Pete Dinham, Natacha Stoehr, Ivo Vranesic, Peter J. Flor, Kurt Lingenhöhl, Will Spooren, C. Gentsch, A. Vassout, Andrzej Pilc, F. Gasparini	2002	40
5	Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils Behavioural Brain Research ·C. Gentsch, Margaret G. Cutler, A. Vassout, Siem J. Veenstra, Felix Brugger	2002	22
6	Non‐invasive, quantitative assessment of the anatomical phenotype of corticotropin‐releasing factor‐overexpressing mice by MRI NMR in Biomedicine ·Nicolau Beckmann, C. Gentsch, Diana Baumann, غفور علی زاده, A. Vassout, Philippe Schoeffter, Erika Loetscher, María Bobadilla, Elias Perentes, Markus Rudin	2001	12
7	NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats Regulatory Peptides ·A. Vassout, Siem J. Veenstra, Kathleen Hauser, Silvio Ofner, Felix Brugger, Walter Schilling, C. Gentsch	2000	43
8	Anxiolytic-Like Effects of the Prototypical Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)pyridine in Rodents Journal of Pharmacology and Experimental Therapeutics ·Will Spooren, A. Vassout, H.C. Neijt, Ralf Kühn, F. Gasparini, Stanley J. Roux, Roger D. Porsolt, C. Gentsch	2000	235
9	The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats Behavioural Brain Research ·Mariusz Papp, A. Vassout, C. Gentsch	2000	72
10	Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity European Journal of Pharmacology ·Will Spooren, A. Vassout, P. C. Waldmeier, C. Gentsch	1998	16
11	CGP57698: A Structurally Simple, Highly Potent Peptidoleukotriene (PLT) Antagonist of the Quinoline Type Advances in experimental medicine and biology ·Bernard Dujardin, Marc Gerspacher, Aneta Łazarska, Gary P. Anderson, Harsha Samtani, N. Subramanian, Howard Ball, C. Gentsch, A. Vassout, M. Lederlin, H. Bittiger, Kathleen Hauser, Karl-Peter Giese, Jst Crest, Michael Bray	1997	2
12	ChemInform Abstract: Phosphinic Acid Analogues of GABA. Part 1. New Potent and Selective GABAB Agonists. ChemInform ·Wolfgang Froestl, Stuart J. Mickel, Roger G. Hall, G. VON SPRECHER, Dietrich Strub, P. A. Baumann, Felix Brugger, C. Gentsch, John L. Van Rynen, H.-R. Olpe, Grety Rihs, A. Vassout, P. C. Waldmeier, H. Bittiger	1995	15
13	CGP 25454A, a novel and selective presynaptic dopamine autoreceptor antagonist Naunyn-Schmiedeberg s Archives of Pharmacology ·Sabine Bischoff, Peter Baumann, J. Krauss, L. Ma�tre, A. Vassout, M. Ochmanska, G Chouinard	1994	1
14	Regulation of Dopamine Receptors by Bupropion: Comparison with Antidepressants and CNS Stimulants Journal of Receptor Research ·A. Vassout, A. Bruinink, J. Krauss, P. C. Waldmeier, Serge Bischoff	1993	23
15	CAN BRAIN REGION-SELECTIVE DOPAMINE (DA) RECEPTOR BLOCKERS PREFERENTIALLY ACT ON SCHIZOPHRENIA SUBTYPES? Clinical Neuropharmacology ·Serge Bischoff, A. Bruinink, J. Iwaz, J. Krauss, Michael T. Schaub, A. Vassout, L. Maître	1992	2
16	Endogenous Dopamine (Da) Modulates [³H]spiperone Binding in Vivo in Rat Brain Journal of Receptor Research ·Serge Bischoff, J. Krauss, 孝則大西, J. Iwaz, Micheline Heinrich, Michael T. Schaub, H. Peric, A. Vassout, P. C. Waldmeier, L. Maître	1991	19
17	The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents Naunyn-Schmiedeberg s Archives of Pharmacology ·Markus Schmutz, Romaissaà Lakhdari, Esteban Muñoz Elcuaz, K. Klebs, A. Vassout, Hans Allgeier, Roland Heckendorn, Graham E. Fagg, H.-R. Olpe, Henk van Riezen	1990	126
18	Interaction of the D₁Receptor Antagonist Sch 23390 with the Central 5-HT System: Radioligang Binding Studies, Measurements of Biochemical Parameters and Effects on L-5-HTP Syndrome Journal of Receptor Research ·Serge Bischoff, Micheline Heinrich, J. Krauss, Matthew A. Sills, Michael Williams, A. Vassout	1988	37
19	Blockade of hippocampal dopamine (da) receptors: A tool for antipsychotics with low extrapyramidal side effects Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Marek Děchtěrenko, Peter Christen, A. Vassout	1988	21
20	Pharmacological Profiles of Four New Tetracyclic Dopamine Antagonists, Maroxepine, Citatepine, Eresepine, and Cipazoxapine Pharmacopsychiatry ·P. C. Waldmeier, Serge Bischoff, H. Bittiger, Kenneth L. Hauser, A. Vassout, A. Delini‐Stula, Juliana Osorio Arredondo, Laurie B. Schenkel, Timothy R. Linden	1986	9

About A. Vassout

A. Vassout is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience, Biological Psychiatry, Pharmacology and Molecular Biology, having authored 31 papers that have together received 2.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (17 papers), Neuroscience and Neuropharmacology Research (12 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Neuropeptides and Animal Physiology (5 papers), Stress Responses and Cortisol (4 papers), Neuroendocrine regulation and behavior (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Pain Mechanisms and Treatments (2 papers). The work is most often cited by research in Biological Psychiatry (410 citations), Behavioral Neuroscience (467 citations), Cellular and Molecular Neuroscience (1.2k citations), Developmental Neuroscience (97 citations) and Neurology (144 citations). A. Vassout has collaborated with scholars based in Switzerland, Poland and United Kingdom. Frequent co-authors include Cédric Mombereau, John F. Cryan, C. Gentsch, A. Delini‐Stula, Will Spooren, Ralf Kühn, F. Gasparini, Stanley J. Roux, H.C. Neijt and Roger D. Porsolt. Their work appears in journals such as European Journal of Pharmacology, Pharmacopsychiatry, Behavioural Brain Research, Naunyn-Schmiedeberg s Archives of Pharmacology and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact